News
Q2 2025 Earnings Call Transcript July 16, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...
Applying a daily emollient on infants younger than aged 9 weeks reduced the risk for atopic dermatitis by 16% at 24 months ...
Livzon Mabpharm Inc.’s anti-IL-17A/F monoclonal antibody, LZM-012, met the primary endpoint in a phase III trial in moderate to severe plaque psoriasis. Conducted at Fudan University’s Huashan ...
Early intervention with IL-17 inhibitors among patients with plaque psoriasis is associated with improved relapse and remission rates.
2h
24/7 Wall St. on MSN4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return PotentialHere are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.
The likelihood of reduced quality of life and high symptom burden in patients with psoriasis was similar across those with low, medium, and high BSA.
2d
Health on MSNWhat To Know About AtherosclerosisMedically reviewed by Angela Ryan Lee, MD Atherosclerosis is a condition where plaque (fatty deposits) builds up inside your arteries, causing them to become stiff and narrow. This can slow or block ...
SMX gains national spotlight as key player in securing defense supply chains – media recognition signals growing market relevance NEW YORK, NY / ACCESS Newswire / July 21, 2025 / A recent editorial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results